Form 4 for DXCM Dexcom
Accepted 2024-05-24 00:00:00 ET · period of report 2024-05-22 · accession 0001093557-24-000115 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-24 | 2024-05-22 | DXCM | Driscoll Rimma | Dir | A - Grant | $0.00 | +2,632 | 6,640 | +66% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-22 | A | A | 2,632 | $0.00 | 6,640 | D | — | — | (F1) The RSU Award was granted on May 22, 2024 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2025 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. (F2) Represents 6,640 restricted stock units, of which 2,632 were granted on May 22, 2024 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2024 Annual Meeting and 4,008 that were granted on August 24, 2023 and will vest over three years until August 24, 2026. |